ETR:SHL

Siemens Healthineers Stock Forecast, Price & News

€49.44

-0.55 (-1.10 %)

(As of 06/21/2021 12:00 AM ET)

Add

Compare

Today's Range

€49.10

▼

€50.00

50-Day Range

€45.18

▼

€49.99

52-Week Range

€35.58

▼

€49.99

Volume376,635 shs

Average VolumeN/A

Market Capitalization$55.72 billion

P/E Ratio32.87

Dividend Yield1.64%

BetaN/A

30 days | 90 days | 365 days | Advanced Chart

Receive SHL News and Ratings via Email

Sign-up to receive the latest news and ratings for Siemens Healthineers and its competitors with MarketBeat's FREE daily newsletter.

About Siemens Healthineers

Siemens Healthineers AG, through its subsidiaries, develops, manufactures, and distributes imaging, diagnostic, and advanced therapies products and services to healthcare providers worldwide. The company operates through three segments; Imaging, Diagnostics, and Advanced Therapies. The Imaging segment offers magnetic resonance, computed tomography, X-ray, molecular imaging, and ultrasound systems. The Diagnostics segment provides in-vitro diagnostic products and services to healthcare providers in laboratory, molecular, and point-of-care diagnostics; and workflow solutions and informatics products. The Advanced Therapies segment offers integrated products, solutions, and services for therapy departments of healthcare providers; and robotic-assisted platform for endo-vascular coronary and peripheral vascular interventions. This segment's principal products include angiography systems and mobile C-arms. It also provides customer value chain services, including design, maintenance, operational management, training, and education services. In addition, the company offers equipment performance management, clinical education and e-learning, asset management, and managed departmental services, as well as digital health products and services. Siemens Healthineers collaborates with HERE Technologies. The company is headquartered in Erlangen, Germany. Siemens Healthineers AG is a subsidiary of Siemens Aktiengesellschaft.

Siemens Healthineers (ETR:SHL) Given a €54.40 Price Target at JPMorgan Chase & Co.
June 21, 2021 | americanbankingnews.com

Siemens Healthineers AG (ETR:SHL) Given Consensus Recommendation of "Buy" by Brokerages
June 18, 2021 | americanbankingnews.com

Kepler Capital Markets Reiterates "€54.00" Price Target for Siemens Healthineers (ETR:SHL)
June 17, 2021 | americanbankingnews.com

Siemens Healthineers (ETR:SHL) PT Set at €54.40 by JPMorgan Chase & Co.
June 15, 2021 | americanbankingnews.com

UBS Group Analysts Give Siemens Healthineers (ETR:SHL) a €48.00 Price Target
June 14, 2021 | americanbankingnews.com

Credit Suisse Group Analysts Give Siemens Healthineers (ETR:SHL) a €55.00 Price Target
June 11, 2021 | americanbankingnews.com

Africa Molecular Diagnostics Market Size to Witness Huge Growth by 2026
March 10, 2021 | marketwatch.com

wireless device to monitor lung sounds market is expected to grow at a CAGR of around 6.3% from 2020 to 2027
March 9, 2021 | marketwatch.com

Radiology Information Systems Market Business Growth And Investment Opportunities, Share and Forecasts 2021 2025 | Says Kenneth Research
March 9, 2021 | marketwatch.com

Global Point-Of-Care Diagnostics Market Will Grow At A CAGR Of 7.3% During The Forecast Period 2019-2025
March 4, 2021 | marketwatch.com

See More Headlines

Industry, Sector and Symbol

Stock Exchange ETR
Industry Diagnostics & Research
Sub-IndustryN/A
SectorMedical
Current SymbolETR:SHL
Previous Symbol
CUSIPN/A
CIKN/A
Webwww.healthcare.siemens.de
Phone49 69 6682 6602
Employees54,300
Year FoundedN/A

Sales & Book Value

Annual Sales$15.02 billion
Price / Sales3.71
Cash Flow€0.59 per share
Price / Cash Flow83.36
Book Value€13.13 per share
Price / Book3.76

Profitability

Debt

Price-To-Earnings

Miscellaneous

Outstanding Shares1,127,100,032
Market Cap$55.72 billion
Next Earnings Date7/30/2021 (Estimated)
OptionableNot Optionable

MarketRank^™

Overall MarketRank^™

1.34 out of 5 stars

2.3 Analyst's Opinion

Consensus Rating
Siemens Healthineers has received a consensus rating of Buy. The company's average rating score is 2.62, and is based on 8 buy ratings, 5 hold ratings, and no sell ratings.
Price Target Upside/Downside
According to analysts' consensus price target of €51.57, Siemens Healthineers has a forecasted upside of 4.3% from its current price of €49.44.
Amount of Analyst Coverage
Siemens Healthineers has been the subject of 10 research reports in the past 90 days, demonstrating strong analyst interest in this stock.

2.1 Community Rank

Outperform Votes
Siemens Healthineers has received 221 “outperform” votes. (Add your “outperform” vote.)
Underperform Votes
Siemens Healthineers has received 302 “underperform” votes. (Add your “underperform” vote.)
Community Sentiment
Siemens Healthineers has received 57.74% “underperform” votes from our community.

MarketBeat's community ratings are surveys of what our community members think about Siemens Healthineers and other stocks. Vote “Outperform” if you believe SHL will outperform the S&P 500 over the long term. Vote “Underperform” if you believe SHL will underperform the S&P 500 over the long term. You may vote once every thirty days.

1.7 Dividend Strength

Dividend Yield
Siemens Healthineers pays a meaningful dividend of 1.64%, higher than the bottom 25% of all stocks that pay dividends.
Dividend Growth
Siemens Healthineers does not have a long track record of dividend growth.
Dividend Coverage
The dividend payout ratio of Siemens Healthineers is 53.19%. This payout ratio is at a healthy, sustainable level, below 75%.

0.0 Company Ownership

Insider Buying vs. Insider Selling
In the past three months, Siemens Healthineers insiders have not sold or bought any company stock.

0.6 Earnings and Valuation

Price to Earnings Ratio vs. the Market
The P/E ratio of Siemens Healthineers is 32.87, which means that it is trading at a more expensive P/E ratio than the market average P/E ratio of about 22.46.
Price to Earnings Ratio vs. Sector
The P/E ratio of Siemens Healthineers is 32.87, which means that it is trading at a less expensive P/E ratio than the Medical sector average P/E ratio of about 43.66.
Price to Book Value per Share Ratio
Siemens Healthineers has a P/B Ratio of 3.76. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.

See Top Rated MarketRank™ Stocks Here

Siemens Healthineers (ETR:SHL) Frequently Asked Questions

Is Siemens Healthineers a buy right now?

13 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Siemens Healthineers in the last twelve months. There are currently 5 hold ratings and 8 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "buy" Siemens Healthineers stock.
View analyst ratings for Siemens Healthineers or view top-rated stocks.

What stocks does MarketBeat like better than Siemens Healthineers?

Wall Street analysts have given Siemens Healthineers a "Buy" rating, but there may be better buying opportunities in the stock market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new stock ideas, but Siemens Healthineers wasn't one of them. MarketBeat thinks these five companies may be even better buys.
View MarketBeat's top stock picks here.

When is Siemens Healthineers' next earnings date?

Siemens Healthineers is scheduled to release its next quarterly earnings announcement on Friday, July 30th 2021.
View our earnings forecast for Siemens Healthineers.

How has Siemens Healthineers' stock been impacted by COVID-19?

Siemens Healthineers' stock was trading at €33.61 on March 11th, 2020 when COVID-19 reached pandemic status according to the World Health Organization (WHO). Since then, SHL shares have increased by 47.1% and is now trading at €49.44.
View which stocks have been most impacted by COVID-19.

Is Siemens Healthineers a good dividend stock?

Siemens Healthineers pays an annual dividend of €0.80 per share and currently has a dividend yield of 1.64%. The dividend payout ratio of Siemens Healthineers is 53.19%. This payout ratio is at a healthy, sustainable level, below 75%.
View Siemens Healthineers' dividend history.

What price target have analysts set for SHL?

13 Wall Street analysts have issued 12-month price targets for Siemens Healthineers' stock. Their forecasts range from €42.00 to €56.00. On average, they anticipate Siemens Healthineers' share price to reach €51.57 in the next year. This suggests a possible upside of 4.3% from the stock's current price.
View analysts' price targets for Siemens Healthineers or view top-rated stocks among Wall Street analysts.

Who are Siemens Healthineers' key executives?

Siemens Healthineers' management team includes the following people:

Dr. Bernhard Montag, Pres, CEO & Chairman of Management Board (Age 52, Pay $2.39M)
Dr. Jochen Schmitz, CFO & Member of Management Board (Age 55, Pay $1.66M)
Dr. Christoph Zindel, Member of Management Board (Age 60, Pay $1.28M)
Ms. Darleen Caron, Chief HR Officer, Labor Director & Member of Management Board (Age 56)
Mr. Marc Koebernick, Head of Investor Relations
Mr. Michel Therin, Pres of Advanced Therapies (Age 60)
Martin Fischer, Head of Fin. Diagnostics
Christian Klaussner, Exec. VP of Fin.
Mr. Deepak S. Nath, Pres of Laboratory Diagnostics (Age 48)

Who are some of Siemens Healthineers' key competitors?

Some companies that are related to Siemens Healthineers include Carl Zeiss Meditec (AFX), Sartorius Aktiengesellschaft (SRT), Renalytix AI (RENX), MaxCyte (MXCT), Profound Medical (PRN), Akumin (AKU), Oncimmune (ONC), Verici Dx (VRCI), Yourgene Health (YGEN), LexaGene (LXG), SQI Diagnostics (SQD), Abingdon Health (ABDX), Cambridge Cognition (COG), genedrive (GDR) and Sernova (SVA).
View all of SHL's competitors.

What other stocks do shareholders of Siemens Healthineers own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Siemens Healthineers investors own include QUALCOMM (QCOM), Illumina (ILMN), Regeneron Pharmaceuticals (REGN), Broadcom (AVGO), Gilead Sciences (GILD), Moderna (MRNA), Koninklijke Philips (PHIA), Vertex Pharmaceuticals (VRTX), Adobe (ADBE) and Applied Materials (AMAT).

What is Siemens Healthineers' stock symbol?

Siemens Healthineers trades on the ETR under the ticker symbol "SHL."

What is Siemens Healthineers' stock price today?

One share of SHL stock can currently be purchased for approximately €49.44.

How much money does Siemens Healthineers make?

Siemens Healthineers has a market capitalization of $55.72 billion and generates $15.02 billion in revenue each year.

How many employees does Siemens Healthineers have?

Siemens Healthineers employs 54,300 workers across the globe.

What is Siemens Healthineers' official website?

The official website for Siemens Healthineers is www.healthcare.siemens.de.

How can I contact Siemens Healthineers?

The company can be reached via phone at 49 69 6682 6602.

This page was last updated on 6/22/2021 by MarketBeat.com Staff

30 Days of MarketBeat All Access for $1.00

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your Risk-Free Trial Subscription Here